
Articles
-
1 week ago |
dagenspharma.dk | Chandni Shah |Mariam E Sunny |Christy Santhosh
Moderna COVID vaccine approved for those 12-64 with risk factorsModerna expects mNEXSPIKE to be ready for 2025-2026 seasonVaccine easier to distribute in developing countriesMay 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
-
2 weeks ago |
today.westlaw.com | Chandni Shah |Sandra Maler
(Reuters) -The U.S. Securities and Exchange Commission (SEC) on Wednesday charged cryptocurrency company Unicoin and three of its top executives, including its CEO and Board Chairman Alex Konanykhin, for false and misleading statements that raised...
-
2 weeks ago |
usatoday.com | Chandni Shah |Nicholas Brown
Sportswear retailer Nike NKE.N is laying off some of its employees in its technology division, a company representative told Reuters on Monday. Nike will shift some of that work to third-party vendors, the representative said in an email, adding that the changes were announced last week. The representative did not specify how many employees were laid off. It is not immediately clear how many people work in Nike's technology division. Bloomberg News first reported the development earlier on Monday.
-
1 month ago |
today.westlaw.com | Prakhar Srivastava |Chandni Shah |Alan Barona
(Reuters) -Aspen Insurance priced its New York initial public offering within its marketed range on Wednesday, raising $397.5 million for the Bermuda-based specialty insurer.
-
1 month ago |
today.westlaw.com | Savyata Mishra |Chandni Shah |Nivedita Bhattacharjee |Disha Mishra
(Reuters) -Instacart head Fidji Simo will step down to join OpenAI as its chief of applications, CEO and co-founder Sam Altman said on Thursday, adding she will report to him and that he will remain head of the Microsoft-backed ChatGPT maker.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →